- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- hetero-4-4-4-mer
- Ligands
- 4 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 8 x GLC: alpha-D-glucopyranose(Non-covalent)
GLC.2: 6 residues within 4Å:- Chain A: I.159, N.160, T.162, V.233, K.234
- Ligands: NAG.5
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:N.160, A:T.162
- Water bridges: A:T.162
GLC.9: 11 residues within 4Å:- Chain A: S.171, S.173
- Chain B: R.100, D.102, N.106, D.108, Y.109
- Chain C: Y.49, R.54, Y.55, S.56
11 PLIP interactions:6 interactions with chain B, 3 interactions with chain C, 2 interactions with chain A- Hydrogen bonds: B:R.100, B:D.102, B:D.102, B:N.106, B:D.108, B:Y.109, C:Y.49, C:S.56, C:S.56, A:S.171
- Water bridges: A:S.173
GLC.12: 6 residues within 4Å:- Chain D: I.159, N.160, T.162, V.233, K.234
- Ligands: NAG.15
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:N.160, D:T.162
- Water bridges: D:T.162
GLC.19: 11 residues within 4Å:- Chain D: S.171, S.173
- Chain E: R.100, D.102, N.106, D.108, Y.109
- Chain F: Y.49, R.54, Y.55, S.56
11 PLIP interactions:6 interactions with chain E, 2 interactions with chain D, 3 interactions with chain F- Hydrogen bonds: E:R.100, E:D.102, E:D.102, E:N.106, E:D.108, E:Y.109, D:S.171, F:Y.49, F:S.56, F:S.56
- Water bridges: D:S.173
GLC.22: 6 residues within 4Å:- Chain G: I.159, N.160, T.162, V.233, K.234
- Ligands: NAG.25
3 PLIP interactions:3 interactions with chain G- Hydrogen bonds: G:N.160, G:T.162
- Water bridges: G:T.162
GLC.29: 11 residues within 4Å:- Chain G: S.171, S.173
- Chain H: R.100, D.102, N.106, D.108, Y.109
- Chain I: Y.49, R.54, Y.55, S.56
11 PLIP interactions:3 interactions with chain I, 2 interactions with chain G, 6 interactions with chain H- Hydrogen bonds: I:Y.49, I:S.56, I:S.56, G:S.171, H:R.100, H:D.102, H:D.102, H:N.106, H:D.108, H:Y.109
- Water bridges: G:S.173
GLC.32: 6 residues within 4Å:- Chain J: I.159, N.160, T.162, V.233, K.234
- Ligands: NAG.35
3 PLIP interactions:3 interactions with chain J- Hydrogen bonds: J:N.160, J:T.162
- Water bridges: J:T.162
GLC.39: 11 residues within 4Å:- Chain J: S.171, S.173
- Chain K: R.100, D.102, N.106, D.108, Y.109
- Chain L: Y.49, R.54, Y.55, S.56
11 PLIP interactions:3 interactions with chain L, 2 interactions with chain J, 6 interactions with chain K- Hydrogen bonds: L:Y.49, L:S.56, L:S.56, J:S.171, K:R.100, K:D.102, K:D.102, K:N.106, K:D.108, K:Y.109
- Water bridges: J:S.173
- 16 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.3: 5 residues within 4Å:- Chain A: E.9, N.12, S.14, Y.210
- Ligands: NAG.5
Ligand excluded by PLIPNAG.4: 4 residues within 4Å:- Chain A: R.69, N.72, W.363, I.395
Ligand excluded by PLIPNAG.5: 5 residues within 4Å:- Chain A: N.160, Y.210, P.211
- Ligands: GLC.2, NAG.3
Ligand excluded by PLIPNAG.6: 2 residues within 4Å:- Chain A: N.255, S.258
Ligand excluded by PLIPNAG.13: 5 residues within 4Å:- Chain D: E.9, N.12, S.14, Y.210
- Ligands: NAG.15
Ligand excluded by PLIPNAG.14: 4 residues within 4Å:- Chain D: R.69, N.72, W.363, I.395
Ligand excluded by PLIPNAG.15: 5 residues within 4Å:- Chain D: N.160, Y.210, P.211
- Ligands: GLC.12, NAG.13
Ligand excluded by PLIPNAG.16: 2 residues within 4Å:- Chain D: N.255, S.258
Ligand excluded by PLIPNAG.23: 5 residues within 4Å:- Chain G: E.9, N.12, S.14, Y.210
- Ligands: NAG.25
Ligand excluded by PLIPNAG.24: 4 residues within 4Å:- Chain G: R.69, N.72, W.363, I.395
Ligand excluded by PLIPNAG.25: 5 residues within 4Å:- Chain G: N.160, Y.210, P.211
- Ligands: GLC.22, NAG.23
Ligand excluded by PLIPNAG.26: 2 residues within 4Å:- Chain G: N.255, S.258
Ligand excluded by PLIPNAG.33: 5 residues within 4Å:- Chain J: E.9, N.12, S.14, Y.210
- Ligands: NAG.35
Ligand excluded by PLIPNAG.34: 4 residues within 4Å:- Chain J: R.69, N.72, W.363, I.395
Ligand excluded by PLIPNAG.35: 5 residues within 4Å:- Chain J: N.160, Y.210, P.211
- Ligands: GLC.32, NAG.33
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain J: N.255, S.258
Ligand excluded by PLIP- 4 x CA: CALCIUM ION(Non-covalent)
CA.7: 6 residues within 4Å:- Chain A: D.219, G.223, D.250, G.271, H.273, G.274
6 PLIP interactions:5 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.219, A:G.223, A:D.250, A:G.271, A:H.273, H2O.4
CA.17: 6 residues within 4Å:- Chain D: D.219, G.223, D.250, G.271, H.273, G.274
6 PLIP interactions:5 interactions with chain D, 1 Ligand-Water interactions- Metal complexes: D:D.219, D:G.223, D:D.250, D:G.271, D:H.273, H2O.24
CA.27: 6 residues within 4Å:- Chain G: D.219, G.223, D.250, G.271, H.273, G.274
6 PLIP interactions:5 interactions with chain G, 1 Ligand-Water interactions- Metal complexes: G:D.219, G:G.223, G:D.250, G:G.271, G:H.273, H2O.43
CA.37: 6 residues within 4Å:- Chain J: D.219, G.223, D.250, G.271, H.273, G.274
6 PLIP interactions:5 interactions with chain J, 1 Ligand-Water interactions- Metal complexes: J:D.219, J:G.223, J:D.250, J:G.271, J:H.273, H2O.63
- 4 x SO4: SULFATE ION(Non-functional Binders)
SO4.8: 5 residues within 4Å:- Chain A: R.44, D.77, R.218, R.297, Y.332
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:Y.332, A:Y.332
- Water bridges: A:R.44
- Salt bridges: A:R.44, A:R.218, A:R.297
SO4.18: 5 residues within 4Å:- Chain D: R.44, D.77, R.218, R.297, Y.332
6 PLIP interactions:6 interactions with chain D- Hydrogen bonds: D:Y.332, D:Y.332
- Water bridges: D:R.44
- Salt bridges: D:R.44, D:R.218, D:R.297
SO4.28: 5 residues within 4Å:- Chain G: R.44, D.77, R.218, R.297, Y.332
6 PLIP interactions:6 interactions with chain G- Hydrogen bonds: G:Y.332, G:Y.332
- Water bridges: G:R.44
- Salt bridges: G:R.44, G:R.218, G:R.297
SO4.38: 5 residues within 4Å:- Chain J: R.44, D.77, R.218, R.297, Y.332
6 PLIP interactions:6 interactions with chain J- Hydrogen bonds: J:Y.332, J:Y.332
- Water bridges: J:R.44
- Salt bridges: J:R.44, J:R.218, J:R.297
- 4 x MAN: alpha-D-mannopyranose(Non-covalent)
MAN.10: 4 residues within 4Å:- Chain C: Q.27, R.93
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.1, NAG-NAG-BMA-MAN-MAN-MAN-MAN.1
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:R.93, C:R.93
MAN.20: 4 residues within 4Å:- Chain F: Q.27, R.93
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.11, NAG-NAG-BMA-MAN-MAN-MAN-MAN.11
2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:R.93, F:R.93
MAN.30: 4 residues within 4Å:- Chain I: Q.27, R.93
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.21, NAG-NAG-BMA-MAN-MAN-MAN-MAN.21
2 PLIP interactions:2 interactions with chain I- Hydrogen bonds: I:R.93, I:R.93
MAN.40: 4 residues within 4Å:- Chain L: Q.27, R.93
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.31, NAG-NAG-BMA-MAN-MAN-MAN-MAN.31
2 PLIP interactions:2 interactions with chain L- Hydrogen bonds: L:R.93, L:R.93
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Venkatramani, L. et al., An Epidemiologically Significant Epitope of a 1998 Human Influenza Virus Neuraminidase Forms a Highly Hydrated Interface in the NA-Antibody Complex. J.Mol.Biol. (2006)
- Release Date
- 2005-12-20
- Peptides
- neuraminidase: ADGJ
FAB heavy chain: BEHK
FAB light chain: CFIL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
AG
AJ
AB
HE
HH
HK
HC
LF
LI
LL
L
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- hetero-4-4-4-mer
- Ligands
- 4 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 8 x GLC: alpha-D-glucopyranose(Non-covalent)
- 16 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x CA: CALCIUM ION(Non-covalent)
- 4 x SO4: SULFATE ION(Non-functional Binders)
- 4 x MAN: alpha-D-mannopyranose(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Venkatramani, L. et al., An Epidemiologically Significant Epitope of a 1998 Human Influenza Virus Neuraminidase Forms a Highly Hydrated Interface in the NA-Antibody Complex. J.Mol.Biol. (2006)
- Release Date
- 2005-12-20
- Peptides
- neuraminidase: ADGJ
FAB heavy chain: BEHK
FAB light chain: CFIL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
AG
AJ
AB
HE
HH
HK
HC
LF
LI
LL
L